Minimally traumatic and inexpensive ceramic laser scalpel
The newly created technology shows an effectiveness more than twice as high as any of the previously developed solid state lasers.Another important feature of this laser is that the generated light has a wavelength of 2 microns, which is the exact wavelength used in surgery. Devices based on this technology are expected to be approximately fours times smaller than the ones, currently used by surgeons. They will also be much cheaper and more reliable. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 20, 2016 Category: Science Source Type: news
Russian scientists develop a minimally traumatic and inexpensive ceramic laser scalpel
(Moscow Institute of Physics and Technology) The newly created technology shows an effectiveness more than twice as high as any of the previously developed solid state lasers.Another important feature of this laser is that the generated light has a wavelength of 2 microns, which is the exact wavelength used in surgery.Devices based on this technology are expected to be approximately fours times smaller than the ones, currently used by surgeons. They will also be much cheaper and more reliable. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 20, 2016 Category: Biology Source Type: news
Laser Hair Removal Plume a Health HazardLaser Hair Removal Plume a Health Hazard
The "burning hair" plume that develops during laser hair removal (LHR) should be considered a biohazard, especially for health care workers," researchers report. Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 15, 2016 Category: Dermatology Tags: Plastic Surgery & Aesthetic Medicine News Source Type: news
Laser Hair Removal Plume a Health Hazard Laser Hair Removal Plume a Health Hazard
The & quot;burning hair & quot; plume that develops during laser hair removal (LHR) should be considered a biohazard, especially for health care workers, & quot; researchers report. < br / > < i > Reuters Health Information < /i > (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 15, 2016 Category: Dermatology Tags: Plastic Surgery & Aesthetic Medicine News Source Type: news
Lasers and topicals both lighten solar lentigines
Quality-switched (QS) laser therapy with a ruby laser and topical triple-combination therapy (TCT) were similarly effective in lightening solar lentigines, based on data from a prospective, open label study of 15 adults. The findings were published in Dermatologic Surgery.
The QS ruby laser... (Source: Skin and Allergy News)
Source: Skin and Allergy News - July 14, 2016 Category: Dermatology Source Type: news
Medical News Today: Transparent skull implant set to ease laser brain surgery
Transparent skull implants promise to provide windows to the brain so surgeons can avoid repeat, invasive surgery to deliver life-saving laser treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 13, 2016 Category: Consumer Health News Tags: Surgery Source Type: news
UCLA faculty voice: Don’t let unqualified doctors perform eye surgery
UCLA
Dr. Bartly Mondino
Dr. Bartly Mondino is chairman of the department of ophthalmology at UCLA and director of the Jules Stein Eye Institute. Dr. Roger Steinert is chairman of the department of ophthalmology at UC Irvine and director of the Gavin Herbert Eye Institute. This op-ed was published in the Los Angeles Daily News.
We never dreamed that we might one day be quoting a pop singer. But in saying, “There’s no shortcut to learning a craft; you just have to put the years in,” Kylie Minogue makes the clearest argument against a proposal being considered by the California Legislature for the fourth straight year....
Source: UCLA Newsroom: Health Sciences - July 13, 2016 Category: Universities & Medical Training Source Type: news
UCLA faculty voice: Don ’t let unqualified doctors perform eye surgery
UCLA
Dr. Bartly Mondino
Dr. Bartly Mondino is chairman of the department of ophthalmology at UCLA and director of the Jules Stein Eye Institute. Dr. Roger Steinert is chairman of the department of ophthalmology at UC Irvine and director of the Gavin Herbert Eye Institute. This op-ed was published in the Los Angeles Daily News.
We never dreamed that we might one day be quoting a pop singer. But in saying, “There’s no shortcut to learning a craft; you just have to put the years in,” Kylie Minogue makes the clearest argument against a proposal being considered by the California Legislature for the fourth straight year....
Source: UCLA Newsroom: Health Sciences - July 13, 2016 Category: Universities & Medical Training Source Type: news
The Triabrain And Answers Unleashed
Have you ever thought about someone and they emailed seconds later? Can thoughts heal your body? Is the brain able to predict new technology? When I first wrote my HuffPost Lucy movie review, people around the globe commented about what I shared regarding the human brain's power. But that article was simply the "tip of the iceberg." I first became knowledgeable about the brain when my mother was in a catastrophic accident, and she required emergency brain surgery to survive. After the surgery, she was tasked with relearning how to eat, walk, talk, and remember again. And I have been by her side ever since. And through ye...
Source: Science - The Huffington Post - July 8, 2016 Category: Science Source Type: news
My sister, my inspiration
Listen to Colton and Lena talk about their relationship.
My little sister, Lena, was born in Denver, Colorado, on Feb. 24, 2000. My recollection of that day and the weeks that followed is hazy — not only because I was just six years old, but also because I was being shuttled between several relatives while my parents attended to some “medical problem” my sister had, which I couldn’t really understand.
The words spina bifida didn’t mean much to me, but between my parents’ solemnity and the fact that — as it was explained to me — the doctors needed to cut into my sister’s back with a laser, I starte...
Source: Thrive, Children's Hospital Boston - July 6, 2016 Category: Pediatrics Authors: Colton Williamson Tags: Diseases & Conditions Our Patients’ Stories Dr. Carlos Estrada Dr. Lawrence Karlin Dr. Mark Proctor spina bifida Source Type: news
A Novel Surgical Procedure for Er:YAG Laser-Assisted Periodontal Regenerative Therapy: Case Series.
Int J Periodontics Restorative Dent. 2016 Jul-Aug;36(4):507-15. doi: 10.11607/prd.2515.AbstractThe objective of this study was to evaluate an Er:YAG laser (ErL) application for periodontal regenerative surgery in angular bone defects at nine sites in six patients. Debridement was thoroughly performed using a combination of curettage with a Gracey-type curette and ErL irradiation at a panel setting of 70 mJ/pulse and 20 Hz with sterile saline spray. After applying an enamel matrix derivative and autogenous bone grafting, ErL was used to form a blood clot coagulation on the grafted bone surface at 50 mJ/pulse and 20 ...
Source: Dental Technology Blog - July 5, 2016 Category: Dentistry Source Type: news
MassDevice.com +5 | The top 5 medtech stories for June 27, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Report: CVRx CEO Yared tapped for AdvaMed chairman
Nadim Yared, the CEO of CVRx, is reportedly slated to replace Becton Dickinson chief executive Vincent Forlenza as chairman of AdvaMed, the medical device industry’s national...
Source: Mass Device - June 27, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
FDA OKs epilepsy trial for MDT’s Visualase MRI-guided laser
Medtronic (NYSE:MDT) said today that the FDA granted an investigational device exemption for a clinical trial of its Visualase ablation device in treating temporal lobe epilepsy.
Fridley, Minn.-based Medtronic put $105 million on the table for Houston-based Visualase back in 2014, including $70 million in up-front cash and another $35 million in milestones. Medtronic had a stake in Visualase and its MRI-guided laser ablation device.
Today the company said the Slate trial is aimed at expanding the indication for Visualase to include drug-resistant mesial temporal lobe epilepsy. The 120-patient trial is designed to track ou...
Source: Mass Device - June 17, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Clinical Trials Neurological Surgical Laser/Light-based Devices Medtronic Visualase Source Type: news
MassDevice.com +5 | The top 5 medtech stories for June 16, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Si-Bone touts updated 510(k) clearance indications, MAC reimbursement wins for iFuse
Si-Bone said this week it won updated 510(k) clearance indications for its iFuse implant system and reimbursement coverage for its minimally in...
Source: Mass Device - June 16, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Boston Scientific wins UK NICE support for GreenLight laser therapy
Boston Scientific (NYSE:BSX) said Tuesday that the U.K.’s National Institute for Health and Care Excellence now provides guidance supporting the use of its GreenLight XPS laser therapy system used to treat prostatic enlargement in patients with benign prostatic hyperplasia.
NICE, which provides evidence-based guidance and standards to the U.K.’s National Health Service, said that adoption of the GreenLight XPS system to treat non high-risk patients with BPH can “significantly reduce costs for the NHS,” Marlborough, Mass.-based Boston Scientific said.
“The GreenLight XPS System is a well-estab...
Source: Mass Device - June 16, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Urology Boston Scientific Source Type: news
